Evidence map›Paper›PMID 33132334›Full record

Observational studyInternal medicine (Tokyo, Japan)2020

Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan.

Yutaro Akiyama, Shinichiro Morioka, Yuji Wakimoto, Akira Kawashima, Kohei Kanda, Ayako Okuhama, Tetsuya Suzuki, Yusuke Miyazato, Hidetoshi Nomoto, Satoshi Ide and 21 more

Abstract readObservational Study
In one paragraph

Observational study in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Yutaro AkiyamaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Shinichiro MoriokaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Yuji WakimotoDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Akira KawashimaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Kohei KandaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Ayako OkuhamaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Tetsuya SuzukiDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Yusuke MiyazatoDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Hidetoshi NomotoDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Satoshi IdeDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Takato NakamotoDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Keiji NakamuraDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Masayuki OtaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Yuki MoriyamaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Saho TakayaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Kota YamadaDepartment of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan.
Maho TaguchiDepartment of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan.
Erika SugitoDepartment of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan.
Shinji IzukaDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Japan.
Kenji IshiguroDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Japan.
Toshiaki KobayashiDivision of Rheumatic Diseases, National Center for Global Health and Medicine, Japan.
Wataru MiyakeDepartment of Cardiology, National Center for Global Health and Medicine, Japan.
Shuji KubotaDepartment of Cardiology, National Center for Global Health and Medicine, Japan.
Masahiro IshikaneDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Noriko KinoshitaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Kei YamamotoDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Mugen UjiieDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Satoshi KutsunaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Kayoko HayakawaDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Sho SaitoDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Norio OhmagariDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective In fever clinics screening coronavirus disease (COVID-19), there could be patients with life-threatening diseases that physicians should not overlook. We exploratorily investigated the final diagnosis among non-COVID-19 hospitalized patients who visited the fever clinic. Methods This was a retrospective, observational, and single-centered study conducted in the National Center for Global Health and Medicine (NCGM), Tokyo, Japan. We conducted a retrospective chart review of patients who visited the fever clinic in the NCGM from 11 March 2020 to 24 April 2020. Patients Patients who met the following clinical criteria visited the fever clinic in the NCGM: (1) body temperature >37.5°C, (2) any symptoms consistent with COVID-19 or (3) referral from local healthcare facilities. In the fever clinic, all patients who met the above criteria had severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test with nasopharyngeal swab specimens. Patients with severe symptoms or an unstable condition were sent to an outpatient clinic for infectious diseases for further evaluation and treatment. Results Among 1,470 patients who visited the fever clinic, 84 patients were hospitalized, and 45 of them were diagnosed as having COVID-19. Among the remaining 39 non-COVID-19 patients, there were nine patients with life-threatening diseases. The life-threatening diseases included acute heart failure, septic shock, pneumocystis pneumonia, peritonsillar abscess, and necrotizing fasciitis. Conclusion Physicians should evaluate each patient carefully while considering other life-threatening conditions even in such a COVID-19 pandemic era.

Indexed as

PandemicsComorbidityCOVID-19FeverHumansJapanRetrospective StudiesRNA, ViralSARS-CoV-2TokyoRNA, Viralcoronavirus diseaseCOVID-19differential diagnosisfever cliniclife-threatening diseases

Identifiers

PMID33132334
PMCPMC7807116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.